CSL Behring

CSL Behring Introduces Larger Vial Sizes for ZEMAIRA, Streamlining Treatment for the Alpha-1 Community

KING OF PRUSSIA, PA — CSL Behring has announced a significant development aimed at improving the treatment experience for patients with Alpha-1 antitrypsin deficiency. The Pennsylvania-based company has introduced 4- …

CSL Behring Introduces Larger Vial Sizes for ZEMAIRA, Streamlining Treatment for the Alpha-1 Community Read More